A Novel Therapeutic Target for Mitochondrial Dysfunction
Mitochondrial dysfunction is a here major contributor to a wide range of chronic diseases. This deficiency in mitochondrial function can lead to cellular failure, ultimately resulting in multiple pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising strategy for addressing this debilitating condition. EPT Fumarate operat